Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2015 | 1 |
2019 | 1 |
2020 | 2 |
2021 | 2 |
2022 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798037
Clinical Trial.
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; HICKORY Study Group.
Peyrin-Biroulet L, et al.
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):128-140. doi: 10.1016/S2468-1253(21)00298-3. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798039
Free article.
Clinical Trial.
Item in Clipboard
Pancreatic endosonographic findings and clinical correlation in Crohn's disease.
Malluta ÉF, Maluf-Filho F, Leite AZA, Ortiz-Agostinho CL, Nishitokukado I, Andrade AR, Lordello MLL, Santos FMD, Sipahi AM.
Malluta ÉF, et al.
Clinics (Sao Paulo). 2019 May 30;74:e853. doi: 10.6061/clinics/2019/e853.
Clinics (Sao Paulo). 2019.
PMID: 31166473
Free PMC article.
Item in Clipboard
The Kluyver effect for trehalose in Saccharomyces cerevisiae.
Malluta EF, Decker P, Stambuk BU.
Malluta EF, et al.
J Basic Microbiol. 2000;40(3):199-205. doi: 10.1002/1521-4028(200007)40:3<199::AID-JOBM199>3.0.CO;2-E.
J Basic Microbiol. 2000.
PMID: 10957961
Item in Clipboard
QUALITY OF LIFE OF PATIENTS FROM A MULTIDISCIPLINARY CLINIC OF INFLAMMATORY BOWEL DISEASE.
Ficagna GB, Dalri JL, Malluta EF, Scolaro BL, Bobato ST.
Ficagna GB, et al. Among authors: malluta ef.
Arq Gastroenterol. 2020 Jan-Mar;57(1):8-12. doi: 10.1590/S0004-2803.202000000-03.
Arq Gastroenterol. 2020.
PMID: 32294729
Free article.
Item in Clipboard
SEROCONVERSION ANALYSIS AFTER HABITUAL HEPATITIS B VACCINATION SCHEME IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES.
Cunha IS, Silva TCD, Malluta ÉF, Scolaro BL, Velho PS, Stall J.
Cunha IS, et al. Among authors: malluta ef.
Arq Gastroenterol. 2020 Jan-Mar;57(1):69-73. doi: 10.1590/S0004-2803.202000000-12.
Arq Gastroenterol. 2020.
PMID: 32294738
Free article.
Item in Clipboard
Disease duration did not influence the rates of loss of efficacy of the anti-TNF therapy in Latin American Crohn’s disease patients.
Kotze PG, Ludvig JC, Teixeira FV, Malluta EF, Miranda EF, Hardt MR, Olandoski M, da Silva Kotze LM, Kleinubing H Jr.
Kotze PG, et al. Among authors: malluta ef.
Digestion. 2015;91(2):158-63. doi: 10.1159/000371655.
Digestion. 2015.
PMID: 25721295
Item in Clipboard
Cite
Cite